User:Mr. Ibrahem/Oprelvekin

Oprelvekin, sold under the brand name Neumega is a medication used to prevent low platelets due to chemotherapy. It is given by injection under the skin. Effects begin after around 7 days and continue for about 7 days after the last dose.

Common side effects include swelling, fast heart rate, shortness of breath, and red eyes. Other side effects may include anaphylaxis, heart failure, and atrial fibrillation. It is a recombinant form of interleukin 11 (IL-11) which primarily stimulates the production of platelets.

Oprelvekin was approved for medical use in the United States in 1997. In the United States it costs about 470 USD per 5 mg vial as of 2021. In Canada it is available via a special access program.